Becton, Dickinson and Co. | BDX - Creditori Commerciali

Prezzo Delle Azioni
152.37
Cambio Giornaliero
0.23 0.15%
Mensile
-1.50%
Annuale
-25.54%
Q2 Previsione
148.88




Creditori Commerciali Cambiamento Data
Abbott USD 4.24B 117M 2025-12
Agilent USD 602M 32M 2025-12
Align Technology USD 121.45M 4.1M 2025-12
AngioDynamics USD 35.39M 3.51M 2025-09
Avanos Medical USD 55.5M 1.3M 2025-12
Baxter International USD 999M 46M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Bio-Rad Laboratories USD 129M 200K 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Danaher USD 1.79B 54M 2026-03
Dentsply International USD 300M 32M 2025-12
Dexcom USD 1.83B 1.38B 2025-12
Edwards Lifesciences USD 227.5M 62.5M 2025-12
Globus Medical USD 98.85M 11.62M 2025-12
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intuitive Surgical USD 1.85B 68.6M 2026-03
J&J USD 10.46B 1.53B 2026-03
Masimo USD 103M 14.9M 2025-12
Medtronic USD 2.57B 12M 2025-12
Solventum Corp USD 687M 18M 2025-12
Stryker USD 1.5B 56M 2025-09
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teleflex USD 130.2M 35.71M 2025-12
Terumo JPY 97.49B 4.46B 2025-12
Thermo Fisher Scientific USD 3.62B 502M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12